LANXESS has been awarded "no-harm certification" from Arbeitsgemeinschaft Qualitätsmanagement Biodiesel e.V. (AGQM) for its new biodiesel stabilizer Baynox Solution 50%. Working closely with oil corporations in Germany, AGQM (a German consortium for biodiesel quality management) investigated the undesirable side-effects of mixing antioxidants for biodiesel with brand-name diesel and their behavior in combustion engines. The LANXESS antioxidant concentrate passed the numerous tests without any restrictions and has been included by AGQM in the no-harm list.
The effective antioxidant Baynox ensures the biofuel obtained from natural raw material remains stable and can therefore be used for longer. The disadvantage of biofuel is that the unsaturated fatty acid structures easily oxidize in contact with atmospheric oxygen. The oxidation of oils and fats through atmospheric oxygen is known as rancidity. Heat, light and other stress factors accelerate this process, making the oil rancid within a short time. The consequences of this oxidation are, on the one hand, a decomposition of the biodiesel into short-chained fatty acids and, on the other, the formation of insoluble polymers (gums). This can cause damage to the engine and the injection system.
LANXESS extends contract with CEO Matthias Zachert
At its ordinary meeting, the Supervisory Board of LANXESS AG appointed Matthias Zachert (55) as CEO of the Group for a further five years, thus extending his contract. The new mandate will begin on April 1, 2024. “Matthias Zachert has decisively transformed LANXESS in just a few years: A ma ... more
Frederique van Baarle assumes position on the LANXESS Board of Management
Frederique van Baarle has taken up her position as a member of the Board of Management and Labor Director at Cologne-based specialty chemicals company LANXESS effective April 1, 2023. Until the end of March van Baarle headed the High Performance Materials business unit at LANXESS, which was ... more
LANXESS increases sales and earnings significantly in fiscal year 2022
In an environment characterised by many upheavals, LANXESS closed fiscal year 2022 successfully. The specialty chemicals company’s sales and earnings have increased significantly. Group sales amounted to EUR 8.088 billion in 2022, up 32.6 percent on the previous year’s figure of EUR 6.101 b ... more
LANXESS is a leading specialty chemicals company and operates in all important markets of the world. Its core business comprises the development, manufacture and sale of high-tech plastics, high-performance rubber, specialty chemicals and intermediates. In addition, it helps its customers i ... more
LANXESS is a specialty chemicals enterprise at the core of the chemical industry that focuses on premium businesses. To this end LANXESS employs an expert workforce with a multitude of different skills – worldwide. The LANXESS corporate philosophy is applied to our products as well as to t ... more
LANXESS is listed as the fourth largest German Chemistry Corporation in the Frankfurt Stock Exchange. With our extensive portfolio we are active in all the markets of the world. Our product pallet ranges from base, specialty and fine chemicals to plastics and rubbers. In addition, we sup ... more
LANXESS granted European patent for Baynox
The European Patent Office has granted LANXESS AG a patent for its product Baynox liquid. The antioxidant concentrate from the specialty chemicals group ensures the long-term stability of the environmentally friendly fuel biodiesel. LANXESS expects the proportion of sales in this area of th ... more
